Ketokaps Med

Ketoprofen, the active ingredient in Ketokaps Med, is a nonsteroidal anti‑inflammatory drug presented as an oral capsule for oral use. It provides pain relief and reduces inflammation in conditions such as rheumatoid arthritis, osteoarthritis and musculoskeletal injuries.

GNH USA supplies Ketokaps Med as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen is used to manage pain and inflammation associated with musculoskeletal and rheumatic disorders.

- Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves function. - Musculoskeletal pain: provides analgesic effect for sprains, strains and back pain. - Acute pain: controls postoperative or injury‑related pain.

Ketoprofen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dyspepsia or stomach discomfort - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Diarrhoea

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Acute renal impairment - Hepatic dysfunction - Severe skin reactions such as Stevens‑Johnson syndrome - Anaphylactic shock - Cardiovascular events such as myocardial infarction

When using Ketokaps Med, several safety considerations should be observed.

- Assess renal function: monitor creatinine and urine output in at‑risk patients. - Monitor hepatic function: check liver enzymes periodically. - Use the lowest effective dose: limit duration to the shortest period necessary. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Caution with anticoagulants: increased risk of bleeding. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ketoprofen can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Warfarin: heightened anticoagulant effect and bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - Corticosteroids: increased risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance renal adverse effects. - Methotrexate: potential for increased toxicity.